BiotechTube
Home/BillionToOne/Oguzhan Atay, PhD
OA

Oguzhan Atay, PhD

Co-Founder, CEO, and Board Chair

BillionToOne

Therapeutic Areas

Prenatal HealthOncology

BillionToOne Pipeline

DrugIndicationPhase
UNITY Complete®Non-Invasive Prenatal Testing (NIPT) for recessive conditions & aneuploidyCommercial
UNITY Expanded RBC Fetal AntigenPrenatal ScreeningCommercial
UNITY Expanded Platelet Fetal AntigenPrenatal ScreeningCommercial
Northstar Select®Pan-Cancer Liquid Biopsy for Therapy SelectionCommercial
Northstar Response®Pan-Cancer Liquid Biopsy for Treatment MonitoringCommercial
Northstar Select® Add-On ApplicationsLiquid BiopsyCommercial

Leadership Team at BillionToOne

DT
David Tsao, PhD
Co-Founder
AP
Anthony Pagano
Board of Directors, Audit Committee Chair
View full BillionToOne profile